CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
You-ting Lin,1 Xue Yang,2 Jing-wei Lv,2 Xue-wu Liu,2,* Sheng-jun Wang2,* 1Department of Neurology, Shandong Provincial Hospital, Shandong University, Ji’nan, People’s Republic of China; 2Department of Neurology, Qilu Hospital, Shandong University, Ji’nan, People&rsq...
Main Authors: | Lin Y, Yang X, Lv J, Liu X, Wang S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | Neuropsychiatric Disease and Treatment |
Subjects: | |
Online Access: | https://www.dovepress.com/cxcl13-is-a-biomarker-of-anti-leucine-rich-glioma-inactivated-protein--peer-reviewed-article-NDT |
Similar Items
-
CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
by: Wei M, et al.
Published: (2020-01-01) -
Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report
by: Lan Hou, et al.
Published: (2022-07-01) -
A case of leucine-rich glioma-inactivated 1 antibody encephalitis with schizophrenia-like symptoms as an initial clinical manifestation
by: Jiyeon Moon, et al.
Published: (2022-10-01) -
The First Case of Familiar Anti-leucine-rich Glioma-Inactivated1 Autoimmune Encephalitis: A Case Report and Literature Review
by: Chuhan Ding, et al.
Published: (2022-04-01) -
Leucine-rich glioma inactivated-1 and voltage gated potassium channel autoimmune encephalitis associated with ischemic stroke; A Case Report
by: Marisa Patryce McGinley, et al.
Published: (2016-05-01)